Paul Clement

Paul Clement is a Professor and Department Chair at the KU Leuven Faculty of Medicine, leading the Department of Oncology. His research spans neuro-oncology, head and neck cancer, and precision medicine, with expertise in immunotherapy, radiation therapy, and translational oncology.

• Projects focus on brain tumor biology, early cancer detection in TP53 mutation carriers, and data-driven precision oncology platforms.
• Recent publications emphasize glioma therapy outcomes, meningioma resistance mechanisms, and single-cell multiomics for personalized treatment.

His work integrates clinical trials (e.g., INTERLINK-1, CATNON trial) with advanced imaging/radiation toxicity studies and cfDNA analysis. Teaching roles include courses in medical oncology, hemato-oncology, and clinical reasoning.